Cargando…
Inhibition of SREBP1 sensitizes cells to death ligands
Evasion of death receptor ligand-induced apoptosis contributs to cancer development and progression. To better understand mechanisms conferring resistance to death ligands, we screened an siRNA library to identify sequences that sensitize resistant cells to fas activating antibody (CH-11). From this...
Autores principales: | Eberhard, Yanina, Gronda, Marcela, Hurren, Rose, Datti, Alessandro, MacLean, Neil, Ketela, Troy, Moffat, Jason, Wrana, Jeffrey L., Schimmer, Aaron D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260812/ https://www.ncbi.nlm.nih.gov/pubmed/21406729 |
Ejemplares similares
-
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism
por: Rotin, Lianne E., et al.
Publicado: (2015) -
Suppression of Cancer Progression by MGAT1 shRNA Knockdown
por: Beheshti Zavareh, Reza, et al.
Publicado: (2012) -
A novel isoflavone, ME-344, targets the cytoskeleton in acute myeloid leukemia
por: Jeyaraju, Danny V., et al.
Publicado: (2016) -
A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity
por: Jitkova, Yulia, et al.
Publicado: (2014) -
A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity
por: Barghout, Samir H., et al.
Publicado: (2021)